BCM
WST icon

Brooktree Capital Management’s West Pharmaceutical WST Stock Holding History

Brooktree Capital Management’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.55M Sell
4,329
-43
-1% -$13.1K 1.01% 20
2026
Q1 		$1.1M Sell
4,372
-787
-15% -$196K 0.87% 22
2025
Q4 		$1.42M Sell
5,159
-140
-3% -$38.3K 0.94% 19
2025
Q3 		$1.39M Buy
5,299
+374
+8% +$90.9K 0.88% 19
2025
Q2 		$1.08M Buy
4,925
+185
+4% +$39.5K 0.7% 21
2025
Q1 		$1.06M Buy
4,740
+154
+3% +$42.4K 0.8% 19
2024
Q4 		$1.5M Sell
4,586
-18
-0.4% -$5.67K 1.11% 18
2024
Q3 		$1.38M Buy
4,604
+139
+3% +$42.6K 1.12% 20
2024
Q2 		$1.47M Sell
4,465
-198
-4% -$70K 1.26% 19
2024
Q1 		$1.85M Buy
4,663
+187
+4% +$69.2K 1.42% 19
2023
Q4 		$1.58M Sell
4,476
-265
-6% -$93.8K 1.27% 20
2023
Q3 		$1.78M Buy
4,741
+141
+3% +$54.5K 1.49% 20
2023
Q2 		$1.76M Sell
4,600
-400
-8% -$143K 1.34% 19
2023
Q1 		$1.73M Buy
5,000
+788
+19% +$230K 1.35% 18
2022
Q4 		$991K Buy
4,212
+68
+2% +$16.1K 0.81% 22
2022
Q3 		$1.02M Buy
4,144
+384
+10% +$117K 0.84% 24
2022
Q2 		$1.14M Buy
3,760
+615
+20% +$200K 0.85% 24
2022
Q1 		$1.29M Buy
+3,145
New +$1.23M 0.84% 25

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Brooktree Capital Management's WST Position: Q2 2026 in Review

Brooktree Capital Management reduced its West Pharmaceutical (WST) stake by 0.98% in Q2 2026, selling an estimated $13.1K and leaving 4,329 shares worth $1.55M. The position accounts for 1.01% of the portfolio, ranked #20.

Brooktree Capital Management first reported a position in WST in Q1 2022 and has held it in 18 quarters since. The position peaked at $1.85M in Q1 2024. 831 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • Brooktree Capital Management held 4,329 shares of West Pharmaceutical worth $1.55M as of Q2 2026.
  • Brooktree Capital Management sold 43 West Pharmaceutical shares in Q2 2026, an estimated $13.1K.
  • West Pharmaceutical made up 1.01% of Brooktree Capital Management's portfolio in Q2 2026, its #20 holding.
  • Brooktree Capital Management first reported a position in West Pharmaceutical in Q1 2022 and has held it in 18 quarters since.
  • Brooktree Capital Management's West Pharmaceutical position peaked at $1.85M in Q1 2024.
  • 831 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Brooktree Capital Management's 13F filing for Q2 2026, filed 5 Aug 2026.